title: Combination therapy with cerivastatin and gemfibrozil causing rhabdomyolysis: is the interaction predictable?
authors.forename: B
authors.initials: B
authors.lastname: Tomlinson
authors.forename: I W
authors.initials: IW
authors.lastname: Lan
mesh_terms: D004359:Drug Therapy, Combination; D015248:Gemfibrozil / Q000008:administration & dosage*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011725:Pyridines; C086276:cerivastatin; D015248:Gemfibrozil